Emerging Therapeutics & Technologies Stream

Cutting-Edge Science and Technology to Deliver New Therapeutic Applications

The Emerging Therapeutics & Technologies stream presents three emerging and fast-developing topics, that represent the latest trends and future outlook for many biologics developers. Emerging Indications for Therapeutic Antibodies will reveal new targets and novel mechanisms of actions for development of next-generation therapeutics beyond oncology. Gene Therapy: Advancing from Bench to Clinic will explore the exciting landscape of gene therapy, highlighting regulatory, commercialization and analytical strategies, and showcasing case studies of gene therapies in rare and neurological diseases. The week closes with a CRISPR for Genome Editing training seminar that will introduce the basic principles of genetic engineering and provide insights into using CRISPR to treat genetic diseases.


Conferences Include:

May 4 - 5

Emerging Indications for Therapeutic Antibodies

May 6 -7

Gene Therapy

May 7 - 8

Genome Editing with CRISPR


Keynote Speakers:

 

Madhusudan Natarajan, PhD Head, Rare Diseases DDU, Takeda


Mike Singer, PhD Medical Officer, Division of Clinical Evaluation and Pharmacology/Toxicology, Center for Biologics Evaluation and Research, FDA

Choose your language
Japanese
Traditional Chinese
Simplified Chinese
Korean


Update History
2020/03/04
Agenda,Sponsor updated
2020/02/13
Agenda,Speaker,Sponsor updated
2020/01/08
Agenda,Sponsor updated
2019/12/09
Event Information updated
2019/11/25
Sponsor updated



View By: